This sugar-coated therapy boosted survival against deadly brain cancer by 50% in mice

Researchers have developed an experimental treatment for glioblastoma, one of the deadliest forms of brain cancer. The approach uses sugar-coated nanoparticles to deliver genetic instructions that restore a tumor-suppressing protein directly into cancer cells—an innovation that overcomes the blood-brain barrier, the body's protective shield that normally blocks therapeutic drugs from reaching the brain. In preclinical mouse studies, the therapy increased median survival by fifty percent while shrinking tumors without noticeable damage to surrounding organs. ScienceDaily reports the research as a potential breakthrough in gene therapy for brain cancers.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton